Singapore invests $100 mn in Indian medical group

One of Singapore's two investment funds said Thursday it had paid $100 million for a minority stake in an Indian medical group, as part of its plan to shifts focus to emerging markets.

The Government of Singapore Corporation (GIC) did not mention the size of the shareholding in Chennai-based Vasan, an eye-care and dental-care specialist, but said the investment reflected the importance it attaches to India.

"The completion of this transaction also underscores our commitment to increase our investments in India," GIC's global head of direct investments Ang Eng Seng in a statement.

The fund in May 2010 bought a 6.58 percent stake in India's Fortis Healthcare, a private hospital chain.

Vasan's chairman and managing director A.M. Arun said the move would boost the company's growth prospects.

According to business consultancy Frost and Sullivan, Vasan was the world's largest eye-care provider with the highest number of stand-alone surgical centres in 2011.

GIC's latest investment is in line with its stipulated shift in focus to emerging markets amid uncertainly over the recovery of the US and European economies. The move was announced in July 2011.

According to GIC's 2010/2011 annual report, investments in Asia accounted for 27 percent of the fund's portfolio as of March 2011, up from 24 percent a year earlier.

GIC says on its website that it manages a portfolio worth over $100 billion ranging from equities to real estate and natural resources in more than 40 countries. Singapore's other sovereign wealth fund is Temasek Holdings.

add to favorites email to friend print save as pdf

Related Stories

Vodafone buys out Essar from India unit for $5 bn

Jul 02, 2011

British mobile phone giant Vodafone is taking full control of its Indian joint venture by buying out its local partner Essar Group, a statement said Saturday, ending a troubled relationship.

Is Singtel hanging up on India?

Jan 26, 2006

The India telecom sector was abuzz with reports that Singtel may be selling out of India ever since October when Vodafone acquired a smallish stake in Bharti Tele-Ventures for a huge $1.5 billion. But if the latest moves ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.